Browse by Author "Barriales Villa, Roberto"

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

2023- Lopes, L.R.; Losi, M.-A.; Sheikh, N.; Laroche, C.; Charron, P.; [et al.]

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

2011- Monserrat Iglesias, Lorenzo; López, Begoña; González, Arantxa; Hermida Prieto, Manuel; Barriales Villa, Roberto; [et al.]

Clinical and functional consequences associated to a PKP2 founder mutation in north-west Spain

2011- Monserrat Iglesias, Lorenzo; Nuñez Fernandez, Lucia; García Estévez, Daniel Apolinar; Barriales Villa, Roberto; Ortiz Genga, Martín; [et al.]

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy

2022- Mirelis, J.G.; Escobar-Lopez, L.; Ochoa, Juan Pablo; Espinosa, M.Á.; Villacorta, E.; [et al.]

Diagnóstico y tratamiento de la miocardiopatía hipertrófica: Comparación de las guías europeas y americanas

2015- Barriales Villa, Roberto

Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure

2023- Cannie, D.E.; Syrris, P.; Protonotarios, A.; Bakalakos, A.; Pruny, J.-F.; [et al.]

Genetics of cardiomyopathies: novel perspectives with next generation sequencing

2015- Monserrat Iglesias, Lorenzo; Castro Beiras, Alfonso; Barriales Villa, Roberto; Ortiz Genga, Martín; García Giustiniani, Daniel [et al.]

Giant ascending aortic aneurysm with impending rupture as presentation of cutis laxa 1B: a case report

2023- Used Gavin, Alejandro; Larrañaga Moreira, José María; Lago Cascudo, Rafael; Mosquera Rodríguez, Victor X; Barriales Villa, Roberto [et al.]

High prevalence of N271I founder mutation in TNNT2 gene detected by NGS in a galician cohort cause hypertrophic cardiomyopathy associated with a benign course

2015- Monserrat Iglesias, Lorenzo; Fernández Fernández, Xusto; Barriales Villa, Roberto; Ortiz Genga, Martín

Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

2022- Gimeno, J.R.; Olivotto, I.; Rodríguez, A.I.; Ho, C.Y.; Fernández, A.; [et al.]

Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

2022- Protonotarios, A.; Bariani, R.; Cappelletto, C.; Pavlou, M.; García-García, A.; [et al.]

iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy

2023- Escribá, R.; Larrañaga Moreira, José María; Richaud-Patin, Y.; Pourchet, L.; Lazis, I.; [et al.]

Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction

2023- Del Monte-Monge, A.; Ruiz-Polo de Lara, Í.; Gonzalo, P.; Espinós-Estévez, C.; González-Amor, M.; [et al.]

Letter by Barriales-Villa et al Regarding Article,"Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies"

2019- Barriales Villa, Roberto; Larrañaga Moreira, José María; Ochoa ., Juan Pablo

Mutations in left ventricular non compaction

2011- Monserrat Iglesias, Lorenzo; Castro Beiras, Alfonso; Fernández Fernández, Xusto; Barriales Villa, Roberto; Cazón Varela, Laura [et al.]

Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker

2019- Lopez-Sainz, Angela; Climent, Vicente; Ripoll-Vera, Tomas; Espinosa, Maria Angeles; Barriales Villa, Roberto; [et al.]

Phenotype and prognostic correlations of the converter region mutations affecting the beta myosin heavy chain

2015- Monserrat Iglesias, Lorenzo; Barriales Villa, Roberto; Ortiz Genga, Martín; García Giustiniani, Daniel; Rodriguez García, Isabel [et al.]

RUNA digital repository

Browse by Author "Barriales Villa, Roberto"

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry ﻿

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy ﻿

Clinical and functional consequences associated to a PKP2 founder mutation in north-west Spain ﻿

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy ﻿

Diagnóstico y tratamiento de la miocardiopatía hipertrófica: Comparación de las guías europeas y americanas ﻿

Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure ﻿

Fabry disease: A new mutation with phenotypic correlation? ﻿

Genética del síndrome de Marfan ﻿

Genética, muerte súbita y deporte ﻿

Genetics of cardiomyopathies: novel perspectives with next generation sequencing ﻿

Giant ascending aortic aneurysm with impending rupture as presentation of cutis laxa 1B: a case report ﻿

High prevalence of N271I founder mutation in TNNT2 gene detected by NGS in a galician cohort cause hypertrophic cardiomyopathy associated with a benign course ﻿

Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry ﻿

Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator ﻿

iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy ﻿

Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction ﻿

Letter by Barriales-Villa et al Regarding Article,"Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" ﻿

Mutations in left ventricular non compaction ﻿

Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker ﻿

Phenotype and prognostic correlations of the converter region mutations affecting the beta myosin heavy chain ﻿

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy

Clinical and functional consequences associated to a PKP2 founder mutation in north-west Spain

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy

Diagnóstico y tratamiento de la miocardiopatía hipertrófica: Comparación de las guías europeas y americanas

Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure

Fabry disease: A new mutation with phenotypic correlation?

Genética del síndrome de Marfan

Genética, muerte súbita y deporte

Genetics of cardiomyopathies: novel perspectives with next generation sequencing

Giant ascending aortic aneurysm with impending rupture as presentation of cutis laxa 1B: a case report

High prevalence of N271I founder mutation in TNNT2 gene detected by NGS in a galician cohort cause hypertrophic cardiomyopathy associated with a benign course

Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy

Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction

Letter by Barriales-Villa et al Regarding Article,"Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies"

Mutations in left ventricular non compaction

Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker

Phenotype and prognostic correlations of the converter region mutations affecting the beta myosin heavy chain